title: Targeting Fas/FasL signaling, a new strategy for maintaining bone health.
abstract: The treatment of osteoporosis has been a critical issue in today's medical situation. Various therapeutic agents and strategies have been investigated and applied, and have proven successful in the treatment of osteoporosis. However, some concerns still remain, such as the adverse effects of such treatments. From this point of view, a search for novel therapeutic targets, such as Fas signaling, remains important.
authors: Yuuki
authors: Y
authors: Imai
authors: Alexander
authors: A
authors: Kouzmenko
authors: Shigeaki
authors: S
authors: Kato
mesh_terms: D001842:Bone and Bones / Q000378:metabolism / Q000502:physiology*; D053222:Fas Ligand Protein / Q000378:metabolism*; D005260:Female; D006801:Humans; D008297:Male; D010024:Osteoporosis / Q000188:drug therapy*; D015398:Signal Transduction / Q000187:drug effects*; D019014:fas Receptor / Q000378:metabolism*
chemical_list: D053222:Fas Ligand Protein; D019014:fas Receptor